A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance
- PMID: 15937772
- DOI: 10.1086/430829
A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance
Abstract
We reviewed all of the published reports of cases of fluoroquinolone treatment failures for respiratory tract infection due to fluoroquinolone-resistant Streptococcus pneumoniae. There were 20 ciprofloxacin and levofloxacin treatment failures reported. Physicians should be aware, when treating pneumococcal respiratory tract infections in older patients with a fluoroquinolone, that clinical failures might occur, especially for patients with comorbid illnesses and a history of recent fluoroquinolone use.
Similar articles
-
Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.Int J Antimicrob Agents. 2009 Jul;34(1):82-5. doi: 10.1016/j.ijantimicag.2009.02.002. Epub 2009 Apr 1. Int J Antimicrob Agents. 2009. PMID: 19342204
-
New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.Infection. 2005 Jun;33(3):106-14. doi: 10.1007/s15010-005-4102-8. Infection. 2005. PMID: 15940410 Review.
-
Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.Int J Antimicrob Agents. 2005 Jul;26(1):62-8. doi: 10.1016/j.ijantimicag.2005.03.010. Int J Antimicrob Agents. 2005. PMID: 15963695
-
Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.Int J Antimicrob Agents. 2006 Sep;28(3):266-9. doi: 10.1016/j.ijantimicag.2006.04.007. Epub 2006 Aug 9. Int J Antimicrob Agents. 2006. PMID: 16904294
-
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.J Antimicrob Chemother. 2004 Feb;53(2):144-8. doi: 10.1093/jac/dkh092. Epub 2004 Jan 16. J Antimicrob Chemother. 2004. PMID: 14729748 Review.
Cited by
-
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.Antimicrob Agents Chemother. 2017 May 24;61(6):e00125-17. doi: 10.1128/AAC.00125-17. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28348151 Free PMC article.
-
Upgrading antibiotic use within a class: tradeoff between resistance and treatment success.Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9655-60. doi: 10.1073/pnas.0600636103. Epub 2006 Jun 13. Proc Natl Acad Sci U S A. 2006. PMID: 16772381 Free PMC article.
-
Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.Antimicrob Agents Chemother. 2007 Jun;51(6):2192-4. doi: 10.1128/AAC.00139-07. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371818 Free PMC article.
-
PEGylating a bacteriophage endolysin inhibits its bactericidal activity.AMB Express. 2011 Oct 7;1:29. doi: 10.1186/2191-0855-1-29. AMB Express. 2011. PMID: 21982426 Free PMC article.
-
Weather-Dependent Risk for Legionnaires' Disease, United States.Emerg Infect Dis. 2017 Nov;23(11):1843-1851. doi: 10.3201/eid2311.170137. Emerg Infect Dis. 2017. PMID: 29048279 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical